Treating these NAFLD mice with kefir peptides for 8 weeks significantly decreased the accumulation of lipid droplets, the expression of 4-HNE, and some proinflammatory cytokines, including IL-6, TNF-α and IL-1β in the liver tissue. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.